BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11885213)

  • 1. Factors affecting substance abuse treatment completion for women.
    Kelly PJ; Blacksin B; Mason E
    Issues Ment Health Nurs; 2001; 22(3):287-304. PubMed ID: 11885213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment compliance among prenatal care patients with substance abuse problems.
    Clark KA; Dee DL; Bale PL; Martin SL
    Am J Drug Alcohol Abuse; 2001 Feb; 27(1):121-36. PubMed ID: 11373030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of emotional and material social support on women's drug treatment completion.
    Lewandowski CA; Hill TJ
    Health Soc Work; 2009 Aug; 34(3):213-21. PubMed ID: 19728480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of program completion for women in residential substance abuse treatment.
    Knight DK; Logan SM; Simpson DD
    Am J Drug Alcohol Abuse; 2001 Feb; 27(1):1-18. PubMed ID: 11373028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's perception of provider, social, and program support in an outpatient drug treatment program.
    Salmon MM; Joseph BM; Saylor C; Mann RJ
    J Subst Abuse Treat; 2000 Oct; 19(3):239-46. PubMed ID: 11027893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in problem severity at assessment and treatment retention.
    Arfken CL; Klein C; di Menza S; Schuster CR
    J Subst Abuse Treat; 2001 Jan; 20(1):53-7. PubMed ID: 11239728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: a prospective study.
    Ravndal E; Vaglum P
    Acta Psychiatr Scand; 1991 Mar; 83(3):217-22. PubMed ID: 2031467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use before and during pregnancy: links to intimate partner violence.
    Martin SL; Beaumont JL; Kupper LL
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):599-617. PubMed ID: 14510043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women in a prenatal care/substance abuse treatment program: links between domestic violence and mental health.
    Martin SL; Kilgallen B; Dee DL; Dawson S; Campbell J
    Matern Child Health J; 1998 Jun; 2(2):85-94. PubMed ID: 10728264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation in a novel treatment component during residential substance use treatment is associated with improved outcome: a pilot study.
    Decker KP; Peglow SL; Samples CR
    Addict Sci Clin Pract; 2014 May; 9(1):7. PubMed ID: 24886745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention.
    Ali B; Green KM; Daughters SB; Lejuez CW
    Addict Behav; 2017 Oct; 73():99-104. PubMed ID: 28500908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial characteristics of pregnant women with and without a history of substance abuse.
    Marcenko MO; Spence M; Rohweder C
    Health Soc Work; 1994 Feb; 19(1):17-22. PubMed ID: 8168773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of successful completion of a halfway-house program for chemically-dependent women.
    Huselid RF; Self EA; Gutierres SE
    Am J Drug Alcohol Abuse; 1991; 17(1):89-101. PubMed ID: 1645496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Child guardianship in a Canadian home visitation program for women who use substances in the perinatal period.
    Mills RM; Siever JE; Hicks M; Badry D; Tough SC; Benzies K
    Can J Clin Pharmacol; 2009; 16(1):e126-39. PubMed ID: 19182306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with attrition rate in a supportive care service for substance using pregnant women in Brazil.
    Avilla RM; Surjan J; de Fátima Ratto Padin M; Canfield M; Laranjeira RR; Mitsuhiro S
    Am J Addict; 2017 Oct; 26(7):676-679. PubMed ID: 28700118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics associated with pregnant women's utilization of substance abuse treatment services.
    Messer K; Clark KA; Martin SL
    Am J Drug Alcohol Abuse; 1996 Aug; 22(3):403-22. PubMed ID: 8841688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of substance abuse treatment programming for women: a review.
    Ashley OS; Marsden ME; Brady TM
    Am J Drug Alcohol Abuse; 2003; 29(1):19-53. PubMed ID: 12731680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting treatment retention among cocaine users.
    Gainey RR; Wells EA; Hawkins JD; Catalano RF
    Int J Addict; 1993 May; 28(6):487-505. PubMed ID: 8486433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers.
    Dobkin PL; De CM; Paraherakis A; Gill K
    Addiction; 2002 Mar; 97(3):347-56. PubMed ID: 11964111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.